Latest news

1 year 7 months ago
This year sees the first European HIV-Hepatitis Testing Week, taking place between 20th - 27th November, with the inclusion of hepatitis an acknowledgment of how important tackling hepatitis C, a leading cause of liver disease, is to public health. Effective testing and screening are central not just to our ability to provide treatment for those living with hepatitis C but also to limit the number of infections. Recent medical advances mean hepatitis C can now be treated quickly, effectively and with limited side effects.
1 year 8 months ago
A report by the Advisory Council on the Misuse of Drugs (ACMD) addresses the treatment of hepatitis C amongst people who use heroin. It highlights how hepatitis C could be eliminated amongst people in drug treatment and how the variations in access to treatment for hepatitis C reduces the likelihood of successful outcomes from drug treatment.
1 year 8 months ago
Darren Millar, Welsh Assembly Member for Clwyd West and Shadow Minister for Health and Social Services, visited Wrexham Maelor Hospital last Friday to find out more about the treatment services on offer for people in North Wales with hepatitis C, as well as other liver disease patients.
1 year 8 months ago
The flu vaccine is provided free by the NHS to those living with serious health conditions as part of the NHS’s ‘Stay Well this Winter’ campaign. For most healthy people, flu is an unpleasant but usually self-limiting disease with recovery taking up to a week. People with flu are approximately 11 times more likely to die if they have an underlying health condition than if they don’t. Chief Medical Officer, Professor Dame Sally Davies, said:
1 year 8 months ago
The National Institute of Clinical Excellence (NICE) have announced which of the new treatments will be made available by the NHS to people living with hepatitis C. The NICE decisions will widen access to a range of new all-oral, direct acting antiviral treatments beyond those patients with decompensated cirrhosis who were treated from 2014 under the Early Access Scheme, and beyond those with cirrhosis who were given access to new treatments earlier this year.
1 year 8 months ago
With around 4000 people in Grampian estimated to have hepatitis C, the virus represents a significant public health and health inequalities issue in the region. With this in mind, Kevin Stewart (MSP for Aberdeen Central and one of The Hepatitis C Trust’s Parliamentary Champions), yesterday visited the Aberdeen Royal Infirmary (ARI) to meet clinical staff involved in the delivery of hepatitis C treatment in Grampian.
1 year 9 months ago
An experimental hepatitis C drug combination from Gilead Sciences Inc.wiped out all strains of the virus in a large clinical trial, giving the company an advantage against AbbVie Inc. in the race to treat as many patients as possible.
1 year 9 months ago
The Hepatitis C Trust yesterday held a highly successful awareness-raising and testing event in Glasgow. The event, which The Hepatitis C Trust staged alongside Waverley Care, was aimed at South Asian communities in Glasgow, who are at particular risk from the virus.
1 year 9 months ago
The Scottish Government yesterday launched the 2015 - 2020 Sexual Health and Blood Borne Virus Framework, and in doing so committed to the elimination of hepatitis C as a public health concern. The Framework drives hepatitis C strategy in Scotland, and represents the next step in the nation's world-leading steps to tackle the virus.
1 year 10 months ago
Public Health England (PHE) in the West Midlands has joined forces with the local NHS, Birmingham City Council and the Hepatitis C Trust to raise awareness of hepatitis and promote the message for people to ‘get tested’. It is estimated that over 5,000 people in Birmingham are living with hepatitis C, however half are undiagnosed. Following World Hepatitis Day (28 July), public health partners have come together to raise awareness of the ‘silent killer’, with two events this week in Birmingham:

Pages